Clinical Trial Update: Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vancomycin for NAAT+/EIA- Clostridioides difficile infection in patients with hematologic diseases, including bone marrow transplant; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Hematologic Diseases
• Oncologic Disorders

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Clostridium Difficile Infection, Hematologic Diseases | Phase 2 | Status: COMPLETED | Results posted: 2026-04-15